An antiretroviral HIV drug has shown effectiveness in reducing infection risk, but the medication could put up some hurdles for physicians and health experts. read more..
Friday, 13 July 2012
Antiretroviral Hiv Drug-Infection Risk-Hiv Prevention-Effectiveness
Sunday, 18 March 2012
Medco Health Solutions Inc-Cancer Treatment-Effectiveness-Side Effects-Cancer Drug
(Reuters) - Many patients taking a widely prescribed class of oral cancer drugs are also using a variety of medications that could reduce the effectiveness of the cancer treatment or increase its toxic side effects, according to research by Medco Health Solutions Inc. For example, 43 percent of patients taking the highly effective leukemia drug Gleevec were also on another medicine that could diminish its efficacy, while 68 percent were taking something that could potentially raise the toxicity level, the study found. ... read more..
Thursday, 8 March 2012
Food And Drug Administration-Antiretroviral Drugs-Health Regulators-Clinical Trial
(Reuters) - U.S. health regulators have approved an expanded label for Merck & Co's treatment for HIV for use with other antiretroviral drugs in children and adolescents. The safety and effectiveness of the drug was evaluated in a clinical trial of 96 children and adolescents of ages 2-18 years with HIV-1 infection, the U.S. Food And Drug Administration said in a statement. The drug, Isentress, was first approved for use in adult patients in October 2007. (Reporting by Shailesh Kuber in Bangalore; Editing by Don Sebastian) read more..